Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- aorta účinky léků metabolismus patofyziologie MeSH
- časové faktory MeSH
- guanidiny aplikace a dávkování antagonisté a inhibitory MeSH
- hypertenze enzymologie patofyziologie MeSH
- inhibitory enzymů aplikace a dávkování farmakologie MeSH
- injekce intravenózní MeSH
- krevní tlak účinky léků MeSH
- krysa rodu Rattus MeSH
- modely kardiovaskulární MeSH
- modely nemocí na zvířatech MeSH
- NG-nitroargininmethylester aplikace a dávkování antagonisté a inhibitory MeSH
- oxid dusnatý metabolismus MeSH
- potkani Wistar MeSH
- renin-angiotensin systém účinky léků MeSH
- srdeční komory účinky léků metabolismus patofyziologie MeSH
- synthasa oxidu dusnatého, typ II MeSH
- synthasa oxidu dusnatého účinky léků fyziologie MeSH
- vazodilatancia aplikace a dávkování farmakologie MeSH
- vazokonstrikce účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- guanidiny MeSH
- inhibitory enzymů MeSH
- NG-nitroargininmethylester MeSH
- Nos2 protein, rat MeSH Prohlížeč
- oxid dusnatý MeSH
- pimagedine MeSH Prohlížeč
- synthasa oxidu dusnatého, typ II MeSH
- synthasa oxidu dusnatého MeSH
- vazodilatancia MeSH
OBJECTIVES: The contribution of the renin-angiotensin system (RAS) and the sympathetic nervous system (SNS) to blood pressure (BP) maintenance was evaluated in rats with N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension. Furthermore, we studied the extent of nitric oxide (NO) synthesis inhibition and the participation of remaining NO in the counterbalance of pressor systems, with a special reference to inducible nitric oxide synthase (iNOS). METHODS: Wistar rats subjected to chronic L-NAME treatment (40 mg/kg per day for 4 weeks) were used. A consecutive blockade of RAS (captopril) and SNS (pentolinium) was followed by acute L-NAME injection. Dimethylguanidine or aminoguanidine were used to affect NO synthesis by iNOS. RESULTS: L-NAME hypertensive rats had borderline augmentation of depressor response to captopril injection, but their BP fall after pentolinium was considerably enhanced compared with controls. Residual BP (recorded after simultaneous blockade of the RAS and the SNS) was elevated by 20-40% in hypertensive rats. Pronounced inhibition of NO synthase activity (50% reduction in the aorta and myocardium) was detected in L-NAME hypertensive rats in which the BP rise elicited by acute L-NAME injection was considerably attenuated (by 60-80%). In contrast, acute administration of dimethylguanidine [mixed endothelial NO synthase (eNOS)/iNOS inhibitor] to hypertensive rats induced a major BP rise similar to that caused by L-NAME injection in controls. Aminoguanidine (a selective iNOS inhibitor) caused a substantial BP rise in L-NAME hypertensive rats only. CONCLUSION: The contribution of SNS to BP maintenance in L-NAME hypertension is more important than that of RAS. In L-NAME hypertensive rats the iNOS becomes a major source of hemodynamically important NO production, which is still insufficient to compensate prevailing vasoconstriction.
Citace poskytuje Crossref.org
Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension
Research on Experimental Hypertension in Prague (1966-2009)
Nitric oxide and salt resistance in Dahl rats: no role of inducible NO synthase